View in EDS HTML Full Text PDF Full Text

Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate.

Saved in:
Bibliographic Details
Title: Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate.
Authors: DIAGO, M.1 (AUTHOR), OLVEIRA, A.2 (AUTHOR), SOLÁ, R.3 (AUTHOR), ROMERO‐GÓMEZ, M.4 (AUTHOR), MORENO‐OTERO, R.5 (AUTHOR), PÉREZ, R.6 (AUTHOR), SALMERÓN, J.7 (AUTHOR), ENRÍQUEZ, J.8 (AUTHOR), PLANAS, R.9 (AUTHOR), GAVILÁN, J. C.10 (AUTHOR), DEL OLMO, J.11 (AUTHOR), URIBARRENA, R.12 (AUTHOR), SILLERO, C.13 (AUTHOR), BENÍTEZ, A.14 (AUTHOR), SÁNCHEZ‐GALDÓN, S.15 (AUTHOR), DALMAU, B.16 (AUTHOR), ERAÑA, L.17 (AUTHOR), MONTORO, M.18 (AUTHOR), PORTU, J.19 (AUTHOR), GARIJO, J. M.20 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Apr2007, Vol. 25 Issue 8, p899-906. 8p. 2 Diagrams, 1 Chart.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/j.1365-2036.2007.03270.x